Authors



Justina Petrullo

Latest:

Sexual and Gender Minority Patients With Chronic Inflammatory Skin Diseases Affected by Obstacles to Care

Sexual and gender minority patients with chronic inflammatory skin diseases may be disproportionately influenced by cost and noncost obstacles to health care.



James Pathoulas, MD

Latest:

Considerations to Best Serve Transgender Patients Seeking Aesthetic Care

Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.


Joshua Fitch, Senior Editor

Latest:

Q+A: Roflumilast cream 0.15% for AD with Eric Simpson, MD, MCR, FAAD

Eric Simpson, MD, MCR, FAAD, lead author of a recently-published article highlighting roflumilast cream 0.15%, joined us for a Q+A interview.


Erin McEvoy

Latest:

Cannabis Extract PHEC-66 Triggers Cell Death in Melanoma, Study Demonstrates

Researchers sought to expand knowledge of the role of cannabis and its molecular mechanisms in anticancer effects.


Christophe Bourdon

Latest:

Addressing Unmet Needs Globally: LEO Pharma’s Commitment to Dermatology

Christophe Bourdon, CEO, discusses LEO Pharma's groundbreaking presentations at EADV, delgocitinib's US pending approval, and the company's commitment to addressing chronic hand eczema.


Ahmad Amin, MD, FAAD

Latest:

Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAAD

Ahmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.



Aderonke Adeboye, PharmD, BCPS

Latest:

Is OX40 Inhibition the Next Game Changer for Atopic Dermatitis?

Learn more about the OX40-OX40L pathway and 2 drugs heading toward phase 3 trials.


Craig Schuette

Latest:

We are Biologic Coordinators of Dermatology (BCoD)

Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.


Jane Bellet, MD

Latest:

Nailing Common, Rare, and Scary Pediatric Nail Conditions and Surgeries

Jane Bellet, MD, will present 2 sessions full of pearls to ensure tiny fingers and toes are cared for in a timely, heartfelt, and effective treatment regimen.


Daphne Chan, PhD, MHEcon

Latest:

AAD, Janssen, and Kenvue Partner to Mentor Next Generation of Dermatologists

Daphne Chan, PhD, MHEcon, discusses the Pathways program, a partnership between the AAD, Janssen, and Kenvue to mentor young, aspiring dermatology providers.


Alexandra K. Golant, MD

Latest:

Alexandra Golant, MD: Insights from Olympic Athlete Suni Lee's Journey with Atopic Dermatitis

Eli Lilly recently hosted a panel discussion with Olympic athlete Suni Lee to discuss the importance of finding a dermatologist who understands the burden of AD.


David Kaplan, MD

Latest:

Educational and Unmet Needs in GPP Management

An expert in dermatology shares his thoughts on the educational and unmet needs in the identification and management of patients with GPP.


Allie Karas, MA

Latest:

Hensin Tsao, MD, PhD: TIL Therapy and Neoadjuvant Treatment for Pigmented Lesions

In this Maui Derm NP+PA Fall session, Tsao discusses the growing trend of TIL therapy and neoadjuvant treatment for pigmented lesions, as well as atypical clinical presentation.


Megha Tollefson, MD

Latest:

Managing Your Pediatric Dermatology Practice and Life: Insights from Brandie Metz, MD, and Megha Tollefson, MD

Metz and Tollefson share insights on efficient practice management, work-life balance, and exciting developments in pediatric dermatology.




Jennifer Holman, MD, FAAD

Latest:

Clinician and Patient Pearls on Managing Atopic Dermatitis

Jennifer Holman, MD, FAAD, and her patient, Audrey Dean, discuss pearls and key take-aways from their experience managing atopic dermatitis. Jennifer Holman wraps up discussing anticipated therapeutic developments and unmet needs.


April W. Armstrong, MD, MPH, Professor and Chief of Dermatology​, University of California, Los Angeles​

Latest:

OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?

Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.


Isabella Tan, Correspondent

Latest:

Advancing Treatment of Solar Lentigines Through the Vasculature Salvage Laser Surgery System

VSLS laser technology offers safe, effective treatment for solar lentigines, minimizing PIH and recurrence with advanced cooling and precision targeting.


Orit Markowitz, MD

Latest:

Orit Markowitz, MD: Cutting Edge Dermatology - Without Cutting the Skin

Orit Markowitz, MD, discusses pearls her SDPA fall conference sessions, "Melanoma Diagnosis, Outcomes and Survival," and "Advanced Conditions."


Lakshi Aldredge, MSN, ANP-BC

Latest:

Take-Home Pearls on the Management of Plaque Psoriasis

Alexa Hetzel, MS, PA-C; Jennifer Conner, MPAS, PA-C; Terry Faleye, MPAS, PA-C; Laura Bush, DMSc, PA-C; and Lakshi Aldredge, MSN, ANP-BC, share take-home messages regarding the treatment of patients with plaque psoriasis, highlighting listening to and educating patients.


Rachael Zimlich, RN, BSN

Latest:

Dermatology NP Practice is Evolving as Demand Increases

There are more than 355,000 nurse practitioners licensed in the United States in a variety of practice areas.


Kevin Kunzmann

Latest:

Vitiligo Linked to Insomnia Risk

A new study showed about half of all vitiligo patients from a care system were burdened with the sleeping disorder.



April Armstrong, MD, MPH

Latest:

April Armstrong, MD, MPH, Shares Insights on the NPF's Psoriasis Health Indicator Report

Armstrong shared insights on the recently released NPF psoriasis health indicator report including pearls on national health data and unmet needs in public health campaigns.


Michael Lewitt, MD

Latest:

A 7-Year-Old Girl With a Recent PsO Diagnosis

Michael Lewitt, MD, discusses a case involving a 7-year-old girl with plaque psoriasis (PsO) affecting body surface area (BSA) and the face, emphasizing the limited pediatric treatment options and the psychological and social impact on the child; the family initially opted for topical treatments like roflumilast, but preferred a more proactive approach, transitioning to apremilast while addressing concerns about gastrointestinal adverse events and the patient’s aversion to needles.


Nuthan Bhat

Latest:

Shin Guard Dermatitis: What's the Diagnosis?

A new allergen, acetophenone azine with generalized autoeczematization, is the cause of “shin guard dermatitis.”

© 2024 MJH Life Sciences

All rights reserved.